News&Resources

SSJR has successfully moved the Court of Appeals for the Federal Circuit to require an additional $130 million bond from AstraZeneca, adding to existing bonds of $312 million, to allow recovery of damages and costs sustained by SSJR’s client Apotex as a result of an injunction. If the trial court’s […]

SSJR attorneys recently appealed claim construction and a finding of non-infringement to the U.S. Court of Appeals for the Federal Circuit on behalf of client Cygnus Medical. The case, originating out of the U.S. District Court for the Western District of Washington in Seattle, concerns a patent owned by Cygnus […]

SSJR attorneys overturned an anticipation rejection by the Patent Office after a successful oral hearing before the Patent Trial and Appeal Board. The patent application concerns a research system and method including a record builder for improving search accuracy and reducing redundancy. All of the claims stood rejected as anticipated […]

On February 13, 2015, SSJR, for its client Apotex, won a patent trial against AstraZeneca, lifting an injunction and clearing the path for Apotex to enter the $1.1 billion annual Pulmicort Respules® market with a generic version of the popular asthma drug. SSJR will now be seeking damages as compensation […]

After an oral argument before the Patent Trial and Appeal Board, SSJR attorneys have secured a reversal of an anticipation rejection by the Patent Office. The patent application, for SSJR Client ABB, concerns a method and system for facilitating a user to establish the cause of a process error that […]